View in EDS HTML Full Text PDF Full Text

Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.

Saved in:
Bibliographic Details
Title: Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.
Authors: Kraft, Colleen S.1 (AUTHOR), Sims, Matthew2,3 (AUTHOR), Silverman, Michael4 (AUTHOR), Louie, Thomas J.5 (AUTHOR), Feuerstadt, Paul6,7 (AUTHOR), Huang, Edward S.8 (AUTHOR), Khanna, Sahil9 (AUTHOR), Berenson, Charles S.10 (AUTHOR), Wang, Elaine E. L.11 (AUTHOR), Cohen, Stuart H.12 (AUTHOR), Korman, Louis13 (AUTHOR), Lee, Christine14 (AUTHOR), Kelly, Colleen R.15 (AUTHOR), Odio, Alberto16 (AUTHOR), Cook, Paul P.17 (AUTHOR), Lashner, Bret18 (AUTHOR), Ramesh, Mayur19 (AUTHOR), Kumar, Princy20 (AUTHOR), De, Ananya11 (AUTHOR), Memisoglu, Asli11 (AUTHOR)
Source: Infectious Diseases & Therapy. Oct2024, Vol. 13 Issue 10, p2209-2210. 2p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938229
DOI:10.1007/s40121-024-01036-8